1171 – 1180 of 1570
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2007
-
Mark
Neurosarcoidosis in a patient with rheumatoid arthritis during treatment with infliximab
(
- Contribution to journal › Letter
-
Mark
Reduced cell proliferation and increased apoptosis are significant pathological mechanisms in a murine model of mild pseudoachondroplasia resulting from a mutation in the C-terminal domain of COMP
(
- Contribution to journal › Article
-
Mark
Prescription of glucosamine for osteoarthritis: does it work and is it safe?
(
- Contribution to journal › Letter
-
Mark
Development of draft validation criteria for a soluble biomarker to be regarded as a valid biomarker reflecting structural damage endpoints in rheumatoid arthritis and spondyloarthritis clinical trials
(
- Contribution to journal › Article
-
Mark
Biomarkers predict radiographic progression in early rheumatoid arthritis and perform well compared with traditional markers
(
- Contribution to journal › Article
-
Mark
Simple counting of nailfold capillary density in suspected systemic sclerosis - 9 years' experience.
(
- Contribution to journal › Article
-
Mark
Down-regulation of human extracellular cysteine protease inhibitors by the secreted staphylococcal cysteine proteases, staphopain A and B.
(
- Contribution to journal › Article
-
Mark
C4b-binding protein and factor h compensate for the loss of membrane-bound complement inhibitors to protect apoptotic cells against excessive complement attack
(
- Contribution to journal › Article
-
Mark
Autonomic and orthostatic dysfunction in primary Sjögren's syndrome
(
- Contribution to journal › Article
-
Mark
Antibody microarray-based serum protein profiling of systemic lupus erythematosus and systemic sclerosis
(
- Contribution to journal › Published meeting abstract